The driver of benefit appears to be the amount of weight lost at 10 years, but the surgery also likely eases OSA symptoms.
Bioprosthetic valve thrombosis found on imaging—with no symptoms reported by the patient—presents a conundrum for clinicians.
Reteplase appears to be another safe and effective thrombolytic option for the treatment of acute ischemic stroke, according ...
Guidelines have downgraded the practice, but new registry data show no increase in bleeding, making a case for pretreatment.
Even since April when the RELIEVE-HF trial came out showing no benefit to an investigational interatrial shunt for heart ...
The findings were published in the Journal of the American College of Cardiology ahead of Juneteenth, the day marking the end ...
With the first positive results from a cardiogenic-shock RCT in hand, researchers are brainstorming what should come next.
The combination of involving pharmacists and using an algorithm to manage GDMT cut LDL levels by 50% in OPTIMIZE PAD-1.
Those who knew him recall a passionate physician and generous collaborator who brought “intellect and zaniness” to his work.
The good news is likely thanks to quality healthcare in Denmark, researchers say, but even with that there’s room to improve.
People whose LDL cholesterol is in the normal range—even those without metabolic risk factors—may yet have levels of ...
Some are calling for a randomized trial, but whether anyone would be willing to randomize is another question entirely.